logo
A black goo was oozing from a ship on the Great Lakes — and teeming with life

A black goo was oozing from a ship on the Great Lakes — and teeming with life

CTV News6 days ago
Research vessel Blue Heron trawls the Great Lakes, gathering data from the water. The floating laboratory's most recent discovery, however, came from an unexpected location: its own rudder.
While docked after a long cruise to study algae blooms in lakes Erie and Superior in September, the crew noticed a black, tar-like substance oozing from the rudder shaft, the mechanism that allows the 87-foot-long (nearly 27-meter-long) boat to change directions. Unsure of what the odd goo was, Doug Ricketts, marine superintendent and senior research associate at the University of Minnesota Duluth's Large Lakes Observatory, brought a cup of the substance to the observatory's scientists for testing.
The scientists were surprised to find that the material was teeming with life-forms, some of which were unknown microorganisms. The mysterious substance, now informally named 'ShipGoo001,' had seemingly been thriving in the oxygen-free environment of the rudder shaft, according to a June 27 university announcement.
'There's no reason to expect any living organisms to be in this part of the ship,' Ricketts said, referring to the closed-off rudder shaft housing. 'This particular piece of a ship doesn't really move a lot. It's not exposed to the rest of the world.'
Black goo
Scientists discovered the material was teeming with life-forms, including some unknown microorganisms. (Cody Sheik via CNN Newsource)
If more goo is found, the goal will be to collect it without disturbing its oxygen-free environment, said lead researcher Cody Sheik, a microbial ecologist at Large Lakes Observatory. More careful study could lead to further discovery of new species of microbes, he added.
'One of the things that's fun about this, is that it was very unexpected. … All of these different things that we make become new habitats that (could be) right for microorganisms,' Sheik said. 'It makes me wonder: What else are we missing by not going out and just looking at something?'
Studying the mysterious goo
While some of the DNA extracted from the black goo was found to be from previously unknown microorganisms, other genetic material in the sample has been observed across the world. When researchers searched global databases, they discovered some DNA was related to microbes from a tarball-type substance in the Mediterranean, a hydrocarbon-contaminated sediment in Calgary, Alberta, and other samples from the coast of California to Germany.
'It's kind of all over the board in terms of what sort of environments these things are being found in,' Sheik said. 'I think we'll get a better idea of what these organisms are capable of by thinking more broadly about the other environments that they're found in.'
The researchers still have many unanswered questions about the odd material, including how it came to be on the ship and whether it is capable of biocorrosion — eating or degrading the ship's steel. Since the substance was in its own sealed environment, it would need a complex food web to be able to thrive and sustain itself.
'(Biocorrosion) is one of the things we have to worry about in oil pipelines and all these other really key infrastructure places. And so, you know, for some of these ships, especially the ones that are really long-lived here on the Great Lakes, because they're in fresh water, is this something where they could be corroding this area? It may be something to think about for future iterations of shipbuilding and things like that,' Sheik said.
Researchers hope to answer these questions in a forthcoming research paper, which will also include the full genomes of the goo's microorganisms so other scientists can build on their work, Sheik added.
Depending on what the researchers find, the material could have practical applications; methane-producing organisms in the substance could have potential use in biofuel production, according to the university's announcement. For now, researchers are keeping an eye out for more of the substance in the ship, and on other vessels, so they can gather additional samples and run further tests.
The origin of the goo
Because there are so many microbial species in the world — potentially up to 1 trillion — finding a new one isn't particularly surprising, said Jeffrey Marlow, an assistant professor of biology at Boston University. 'It's all about where they're found and what their genomic history or metabolic capacity is — that's what often makes a new species particularly exciting,' he added in an email.
To ascertain the origin of the substance, Sheik and his team are putting together a history of the ship, as the former fishing boat was purchased pre-owned nearly three decades ago by the University of Minnesota Duluth. While the ship's rudder is not meant to be lubricated with anything other than water, it's possible that the previous owners oiled that area and those organisms laid dormant for years. What's more, the goo was not present during the ship's last inspection in November 2021.
Marlow, who was not involved in the discovery, hypothesized that the ooze could have wound up in the rudder shaft by catching a ride on marine snow — clumps of dead organic matter that sink through the water column and contain oxygen-free pockets, he explained.
Sheik plans to explore the goo's origin, noting that there are many scenarios to consider, including whether the substance grew in the rudder shaft in the first place or somehow hitched a ride on the boat.
'One of the coolest parts of this story is the fact that the sample made it to the microbiologists in the first place — it speaks to a 'microbiologically literate' culture where several people had the awareness and curiosity to ask what might be living in an otherwise inconvenient ooze,' Marlow said. 'It makes you wonder what other fascinating microbes could be living around us in the most unexpected places.'
By Taylor Nicioli, CNN
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space
NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space

CTV News

time4 hours ago

  • CTV News

NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space

Astronaut Butch Wilmore is retiring from NASA less than five months after he returned from a troubled test mission that left him aboard the International Space Station far longer than expected, the space agency announced Wednesday. Wilmore, along with NASA astronaut Suni Williams, piloted the first crewed flight of Boeing's Starliner spacecraft last year. The mission gained worldwide attention when the spacecraft experience several serious issues en route to the space station, including thruster outages and gas leaks. Williams and Wilmore had been expected to stay about eight days in orbit. But NASA and Boeing spent weeks attempting to pinpoint what went wrong with their vehicle and assessing whether Starliner was safe to carry the astronauts home. The space agency ultimately decided returning the duo to Earth aboard Starliner was too risky a proposition. NASA announced last August that Williams and Wilmore would join the next International Space Station crew rotation along with two other astronauts on SpaceX's Crew-9 mission and remain aboard the orbiting laboratory for several additional months. Williams and Wilmore ultimately returned home in March — more than nine months after they left Earth. Such a duration of stay in orbit is not uncommon, as astronauts routinely live on the space station for six months or longer when they serve on staff rotation missions. 'Legacy of fortitude' Both astronauts have maintained the position that they were fully prepared for their extended stay in space, saying they each understood the risks and uncertainty associated with test flying a spacecraft for the first time. Williams and Wilmore also repeatedly sought to quash narratives that they were 'abandoned,' 'stuck' or 'stranded' in space. 'That's been the narrative from day one: stranded, abandoned, stuck — and I get it, we both get it,' Wilmore told CNN's Anderson Cooper in February. 'Help us change the narrative, let's change it to: prepared and committed despite what you've been hearing. That's what we prefer.' Wilmore's 'commitment to NASA's mission and dedication to human space exploration is truly exemplary,' said Steve Koerner, the acting head of NASA's Johnson Space Center in Houston, where astronauts train, in a statement Wednesday. 'His lasting legacy of fortitude,' Koerner added, 'will continue to impact and inspire the Johnson workforce, future explorers, and the nation for generations.' Wilmore's departure from NASA follows the example set by Bob Behnken and Doug Hurley, the two astronauts who piloted the first crewed test flight of SpaceX's Crew Dragon capsule in 2020. That mission marked the last for both Behken and Hurley, who have each since retired. Wilmore, a Naval officer and test pilot who served in 21 combat missions, joined NASA's astronaut corps in 2000. He flew on three missions during his 25 years of service, including a mission on the space shuttle Atlantis and a trip to the space station on a Russian Soyuz spacecraft. Notably, upon his return to Earth on a SpaceX capsule in March, Wilmore said that he would theoretically fly aboard one of Boeing's Starliner capsules again if given the opportunity. 'We're going to rectify all the issues that we encountered. We're going to fix them, we're going to make it work,' Wilmore said during a March 31 news conference. 'And with that, I'd get on in a heartbeat.' By Jackie Wattles, CNN

What's slimy, green and flourishing thanks to climate change?
What's slimy, green and flourishing thanks to climate change?

CBC

time7 hours ago

  • CBC

What's slimy, green and flourishing thanks to climate change?

If you guessed algae, you're right. New research published in Communications Earth & Environment suggests algae growth is increasing in Canada's lakes — even remote ones — and climate change is the main culprit. A team led by researchers at McGill University in Montreal and Université Laval analyzed sediment cores taken from 80 lakes across the country and found that algae has been increasing in the majority of them since the mid-1800s. For lead author Hamid Ghanbari, the most interesting finding was a spike in the rate of the increase in algal growth: since the 1960s, it increased sevenfold. "This was something very surprising for us and when we compared our data with other historical records, we found out that rising temperature is a major factor," Ghanbari said. Aside from climate change, excess nitrogen and phosphorus can also contribute to algal growth when they are carried into waterways through runoff from animal manure and chemical fertilizers, stormwater and wastewater. Algae, along with bacteria and phytoplankton, are essential for the aquatic food web. But too much algae can be a bad thing. The recently published peer-reviewed study looked at algal growth overall and didn't analyze for blooms. While some lakes see some algae as a part of their cycle, Ghanbari said the concern is what will happen if the increase in algae leads to growth outside of what's normal. "That's where the problem starts," he said. "We don't know at the moment what that threshold is, but we know the increasing chlorophyll or algae levels in the lakes could lead to several problems." Ghanbari said excess algae growth can harm aquatic life and even human health — reducing water quality, depleting oxygen in the water and creating blooms that can release dangerous toxins, as residents along the shores of Lake Erie know all too well. Daryl McGoldrick, head of water quality monitoring and surveillance for the Great Lakes for Environment and Climate Change Canada, said while increasing algal growth doesn't necessarily mean more toxic blooms, there is a risk to aquatic life. "The study is in line with what we see and [what we] suspect are impacts of warming," McGoldrick said. Global and local action can help Maëlle Tripon, a project manager with Quebec freshwater advocacy group Fondation Rivières, said her team has noticed first-hand that when it's warmer, they see more algae on lakes. She said her takeaway from the research is that tackling algal growth cannot solely rely on local action. "We already knew we need to change locally — like farming practices and also, for example, we need less paved and waterproof surface in the cities," she said. "But what the study shows is that we also need global policies to alleviate climate change." Ghanbari agreed, but added that individual choices can still help reduce algal growth. "Simple acts such as reducing the fertilizers … or properly disposing of household chemicals, these simple acts could really help the lakes," he said.

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

National Post

time15 hours ago

  • National Post

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

Article content AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ('IPA' or the 'Company'), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies (Europe) B.V. ('IPA Europe'), to AVS Bio for a total enterprise value of $12 million USD. AVS Bio, a portfolio company of Arlington Capital Partners, is a leading global provider of critical inputs and services for the bioprocessing and biologics industries. The transaction generated $11.7 million USD in net proceeds on a cash-free, debt-free basis. Article content This transaction marks a meaningful step in IPA's strategic refinement—streamlining its operational footprint, strengthening its balance sheet, and allowing the Company to concentrate resources on its most impactful growth areas. The proceeds will support investment in scientific platforms, data-driven discovery technologies, and expansion of key strategic programs. Article content Article content 'This transaction delivers strong value to IPA and our investors,' said Dr. Jennifer Bath, President and CEO of ImmunoPrecise Antibodies Ltd. 'It reflects our disciplined strategy to focus resources on our AI-based Software as a Service (SaaS) platform—where we're combining scientific expertise with advanced technologies to accelerate modern biologics discovery. We're proud of the business we've built in the Netherlands and confident it will continue to thrive under AVS Bio's ownership.' Article content IPA's global operations span biologics discovery, engineering, and characterization, supported by LENS ai ™, the Company's proprietary platform powered by HYFT® multi-omics technology. LENS ai helps unify and interpret complex biological data, enabling more integrated insights and smarter decisions across the discovery and development process. By harmonizing data across modalities, the platform supports faster identification of opportunities and reduces inefficiencies that typically slow biologics innovation. Article content The sale was conducted through a competitive, arm's-length process. A 12-month Transition Services Agreement (TSA) will provide continuity across key functions during the transition. IPA holds no material ongoing relationship with AVS Bio or its affiliates beyond the scope of the transaction. Article content Edgemont Partners served as exclusive financial advisor to IPA. Article content About ImmunoPrecise Antibodies Ltd. Article content ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is a biotherapeutics company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies—such as its LENSai™ platform—to accelerate drug discovery and improve decision-making across complex biological systems. IPA supports global partners in advancing novel therapeutics, diagnostics, and translational research. Article content Headquartered in Norwich, CT, AVS Bio is a global provider of specific pathogen-free (SPF) laboratory products and services that support the development and manufacture of vaccines, therapeutics, and biologics. The Company supplies leading manufacturers with critical bioprocessing inputs including SPF eggs, antigens, and antibodies, and also offers diagnostic testing and GMP support services. AVS Bio operates more than 20 facilities across North America and Europe and is a portfolio company of Arlington Capital Partners. Article content Article content . Article content About Arlington Capital Partners Article content Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington's website at Article content Article content and follow Arlington on LinkedIn. Article content Forward-Looking Statements Article content This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as 'expects,' 'intends,' 'plans,' 'anticipates,' 'believes,' 'potential,' or similar expressions, or by statements that certain actions, events, or results 'may,' 'will,' 'could,' or 'might' occur or be achieved. These include, but are not limited to, statements regarding the anticipated benefits of the divestiture of IPA Europe, the Company's strategic focus on its AI-native platforms, projected scalability and market adoption of its LENSai™ platform, and the impact of reinvestment into data-driven, biologics discovery technologies. Article content Forward-looking statements are based on management's current expectations, assumptions, and projections about future events and Company performance. Actual results could differ materially from those expressed or implied due to factors beyond the Company's control, including: operational challenges in transitioning the divested business; execution risks related to AI-driven platform scaling; the pace and accuracy of scientific and technological innovation; changes in competitive dynamics within SaaS and biologics R&D markets; customer adoption rates; and shifts in economic, market, or regulatory conditions. Article content Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied herein. Additional information about these and other risks and uncertainties is set out in the Company's Annual Report on Form 20-F, as amended, for the fiscal year ended April 30, 2025, available on the Company's SEDAR+ profile at and EDGAR profile at If any of these risks materialize, the Company's actual results, performance, or achievements could vary significantly from those currently anticipated. Article content Article content Article content Article content Article content Contacts Article content Investor Contact Article content Article content Louie Toma, CPA, CFA

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store